Alopecia: Managing the Basics

    Thamer Mubki, Jerry Shapiro
    Image of study
    TLDR The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.
    The 2015 document provides an overview of the role of androgens in hair growth, the diagnosis and treatment of female pattern hair loss (FPHL), and the evaluation and management of hirsutism. It explains that androgens, particularly dihydrotestosterone (DHT), are central to hair growth and related conditions. FPHL, affecting 6% to 38% of women depending on age, is often diagnosed clinically and can be confirmed with a skin biopsy. Treatments for FPHL include minoxidil, which benefits 60% of women, and off-label androgen-dependent therapies. For hirsutism, which is scored using the Ferriman-Gallwey system, treatment options include cosmetic measures, medical therapies like oral contraceptives and antiandrogens, and topical eflornithine cream. The document emphasizes the importance of realistic expectations for hair loss treatments and the necessity of treating hirsutism regardless of severity.
    Discuss this study in the Community →

    Cited in this study

    27 / 27 results

    Related

    14 / 14 results